Clinical Trials · NCT06446531
Prevention of Progression of Prediabetes, Obesity and CV Risk
- Phase
- Phase 1
- Recruitment status
- Recruiting
- Sponsor
- The University of Texas Health Science Center at San Antonio
- Enrollment
- 64
- Start date
- Sep 2024
- Locations
- 1 site, United States
- Primary endpoint
- Hemoglobin A1c Level (HBA1c)